JYNT
JOINT Corp
$8.20
-1.09%
$119.9M
No data for this timeframe.
Vol
Market Cap$119.9M
Cap SizeMicro Cap
Inst. Holders7 funds
Inst. Value$12.2M
Inst. Activity4 buys / 0 sells
Insider Activity5B / 0S
Insider Net $$1.4M
SEC Reports4
Recent Activity
May 21, 2026
other
The Joint Corp. Announces Milind Pant Elected as Director
<p align="center"><em>- Global Executive with Extensive Digital and International Franchise-Led Grow
May 20, 2026
Insider
Rubel Matthew E sold 5,714 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
DaVella Ronald V sold 5,714 shares
Director @ $0.00 ($0.00)
May 20, 2026
Insider
Grandpre Christopher M sold 5,714 shares
Director @ $0.00 ($0.00)
May 1, 2026
SEC
Joint Corp announced the sale of 45 company-owned/managed clinics in Southern California to Elite Chiro Group for $2.3 m
8-K — Impact 4/10
Apr 24, 2026
SEC
The Joint Corp (JYNT) is selling 45 company-owned or managed chiropractic clinics in Southern California to Elite Chiro
8-K — Impact 5/10
Apr 23, 2026
SEC
The Joint Corp. announced it will report its Q1 2026 financial results on May 7, 2026, after market close, with a confer
PRESS-RELEASE — Impact 3/10
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — ADD
66,621 shares ($580.9K)
Price Targets
Historical data — last covering-analyst action Aug 2025. No current recommendation available.
$10.00 (Aug 2025)
Current $8.41
Low $9.00
Median $9.00
High $12.00
3 analysts
$9.00
$12.00
Analyst Ratings
2Strong Buy
4Buy
4Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 8, 2025 | B. Riley Securities | MAINTAIN | Buy → Buy |
| May 9, 2025 | Lake Street | MAINTAIN | Buy → Buy |
| Nov 8, 2024 | Roth MKM | MAINTAIN | Buy → Buy |
| May 6, 2024 | B. Riley Securities | MAINTAIN | Buy → Buy |
| May 3, 2024 | Roth MKM | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.07 ▲ +68.8% | $-0.02 — $0.13 | 213% YoY | 4 |
| Next Q | $0.09 ▲ +30.8% | $-0.03 — $0.16 | -35% YoY | 4 |
| Current FY | $0.28 ▲ +10.7% | $0.03 — $0.43 | 1483% YoY | 3 |
| Next FY | $0.43 | $0.03 — $0.69 | 57% YoY | 3 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $8.7M | — |
| RENAISSANCE TECHNOLOGIES LLC | $2.1M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $580.9K | ADD |
| MORGAN STANLEY | $444.4K | TRIM |
| WELLS FARGO & COMPANY/MN | $135.0K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Rubel Matthew | A | $0.00 |
| May 20, 2026 | DaVella Ronald | A | $0.00 |
| May 20, 2026 | Grandpre Christopher | A | $0.00 |
| May 20, 2026 | Karrmann Sandra | A | $0.00 |
| May 20, 2026 | Pant Milind | A | $0.00 |
7 institutional holders with $12.2M total value (1,393,865 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, CHARLES. Net buying activity: 4 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,000,787 | $8.7M | 71.8% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 235,378 | $2.1M | 16.9% | — |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 66,621 | $580.9K | 4.8% | ADD +88.5% |
| 4 | MORGAN STANLEY | 50,968 | $444.4K | 3.7% | TRIM -51.6% |
| 5 | WELLS FARGO & COMPANY/MN | 15,476 | $135.0K | 1.1% | ADD +78.0% |
| 6 | BANK OF AMERICA CORP /DE/ | 12,868 | $112.2K | 0.9% | ADD +73.0% |
| 7 | FMR LLC | 11,767 | $102.6K | 0.8% | DOUBLED +490.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 35,339 | 66,621 | +88.5% | $580.9K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 8,692 | 15,476 | +78.0% | $135.0K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 7,440 | 12,868 | +73.0% | $112.2K | 2025-Q4 |
| FMR LLC | DOUBLED | 1,992 | 11,767 | +490.7% | $102.6K | 2025-Q4 |
| UBS Group AG | ADD | 9,601 | 12,869 | +34.0% | $122.8K | 2025-Q3 |
| FMR LLC | TRIM | 6,919 | 1,992 | -71.2% | $19.0K | 2025-Q3 |
| UBS Group AG | TRIM | 15,231 | 9,601 | -37.0% | $110.8K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 5,202 | 7,790 | +49.8% | $89.9K | 2025-Q2 |
| FMR LLC | TRIM | 10,373 | 6,919 | -33.3% | $79.8K | 2025-Q2 |
| CITADEL ADVISORS LLC | TRIM | 46,938 | 21,639 | -53.9% | $270.3K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 131,196 | 63,466 | -51.6% | $674.6K | 2024-Q4 |
| UBS Group AG | ADD | 7,853 | 14,946 | +90.3% | $158.9K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 3,353 | 5,088 | +51.7% | $54.1K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 33,175 | — | $379.5K | 2024-Q3 |
8 unique insiders with 5 transactions. Net insider value: $1.4M ($1.4M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Rubel Matthew E | Director | A | 5,714 | $0.00 | $0.00 |
| May 20, 2026 | DaVella Ronald V | Director | A | 5,714 | $0.00 | $0.00 |
| May 20, 2026 | Grandpre Christopher M | Director | A | 5,714 | $0.00 | $0.00 |
| May 20, 2026 | Karrmann Sandra R | Director | A | 5,714 | $0.00 | $0.00 |
| May 20, 2026 | Pant Milind | Director | A | 5,714 | $0.00 | $0.00 |
| May 13, 2026 | JOBSON CHARLES E | 10%+ Owner | BUY | 20,375 | $8.57 | $174.6K |
| May 12, 2026 | JOBSON CHARLES E | 10%+ Owner | BUY | 127,676 | $8.57 | $1.1M |
| Apr 21, 2026 | JOBSON CHARLES E | 10%+ Owner | BUY | 509 | $8.58 | $4.4K |
| Mar 9, 2026 | Razdan Sanjiv Kumar | See Remarks | A | 73,484 | $0.00 | $0.00 |
| Mar 9, 2026 | Bowman Scott Justin | Chief Financial Officer | A | 28,301 | $0.00 | $0.00 |
| Feb 12, 2026 | JOBSON CHARLES E | 10%+ Owner | BUY | 15,397 | $8.50 | $130.9K |
| Feb 11, 2026 | JOBSON CHARLES E | 10%+ Owner | BUY | 448 | $8.70 | $3.9K |
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.5/10.
NEUTRAL
8-K
4/10
Joint Corp announced the sale of 45 company-owned/managed clinics in Southern California to Elite Ch
May 1, 2026
NEUTRAL
8-K
5/10
The Joint Corp (JYNT) is selling 45 company-owned or managed chiropractic clinics in Southern Califo
Apr 24, 2026
NEUTRAL
PRESS-RELEASE
3/10
The Joint Corp. announced it will report its Q1 2026 financial results on May 7, 2026, after market
Apr 23, 2026
NEUTRAL
DEFA14A
2/10
The Joint Corp filed a DEFA14A, which is a definitive additional materials filing related to a share
Apr 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Aug 2025): 60% buy across 10 analysts — 2 strong buy, 4 buy, 4 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Aug 2025. No current recommendation available.
$10.00 mean target (Aug 2025)
$9.00 Low
$12.00 High
| Metric | Value |
|---|---|
| Current Price | $8.41 |
| Target Low | $9.00 |
| Target Mean | $10.00 |
| Target Median | $9.00 |
| Target High | $12.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.07 | $-0.02 | $0.13 | 212.5% | +68.8% | 0↑ 1↓ | $0.0B | 9.8% | 4 |
| Next Q 2026-09-30 |
$0.09 | $-0.03 | $0.16 | -34.9% | +30.8% | 0↑ 1↓ | $0.0B | 10.7% | 4 |
| Current FY 2026-12-31 |
$0.28 | $0.03 | $0.43 | 1483.4% | +10.7% | 0↑ 1↓ | $0.1B | 9.8% | 3 |
| Next FY 2027-12-31 |
$0.43 | $0.03 | $0.69 | 56.6% | — | 1↑ 0↓ | $0.1B | 3.0% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.068 | |
| 7d ago | $0.040 | +0.028 |
| 30d ago | $0.040 | +0.028 |
| 60d ago | $0.040 | +0.028 |
| 90d ago | $0.040 | +0.028 |
8 analyst firms have rated this stock: 3 upgrades, 5 downgrades, 6 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Aug 8, 2025 | B. Riley Securities | MAINTAIN | Buy | Buy |
| May 9, 2025 | Lake Street | MAINTAIN | Buy | Buy |
| Nov 8, 2024 | Roth MKM | MAINTAIN | Buy | Buy |
| May 6, 2024 | B. Riley Securities | MAINTAIN | Buy | Buy |
| May 3, 2024 | Roth MKM | REITERATE | Buy | Buy |
| Sep 14, 2023 | Roth MKM | MAINTAIN | Buy | Buy |
| Aug 11, 2023 | Roth MKM | MAINTAIN | Buy | Buy |
| Aug 11, 2023 | Maxim Group | DOWNGRADE | Buy | Hold |
| Mar 13, 2023 | DA Davidson | UPGRADE | Underperform | Neutral |
| Aug 8, 2022 | DA Davidson | MAINTAIN | — | Underperform |
| Aug 5, 2022 | B. Riley Securities | UPGRADE | Neutral | Buy |
| Aug 5, 2022 | Maxim Group | UPGRADE | Hold | Buy |
| May 10, 2022 | DA Davidson | DOWNGRADE | Buy | Underperform |
| May 9, 2022 | DA Davidson | DOWNGRADE | Buy | Underperform |
| May 6, 2022 | Craig-Hallum | DOWNGRADE | Buy | Hold |
| Feb 25, 2022 | DA Davidson | MAINTAIN | — | Buy |
| Aug 9, 2021 | DA Davidson | MAINTAIN | — | Buy |
| Aug 6, 2021 | Roth Capital | MAINTAIN | — | Buy |
| Jun 28, 2021 | Roth Capital | MAINTAIN | — | Buy |
| Jun 3, 2021 | Maxim Group | DOWNGRADE | Buy | Hold |
| May 10, 2021 | DA Davidson | MAINTAIN | — | Buy |
| Apr 7, 2021 | DA Davidson | MAINTAIN | — | Buy |
| Mar 5, 2021 | DA Davidson | MAINTAIN | — | Buy |
| Nov 9, 2020 | DA Davidson | MAINTAIN | — | Buy |
| Jun 11, 2020 | DA Davidson | MAINTAIN | — | Buy |
| Mar 27, 2020 | B. Riley Securities | MAINTAIN | — | Buy |
| Mar 6, 2020 | B. Riley Securities | MAINTAIN | — | Buy |
| Nov 12, 2019 | DA Davidson | MAINTAIN | — | Buy |
| Jun 20, 2019 | B. Riley Securities | INITIATE | — | Buy |
| Jan 18, 2019 | DA Davidson | INITIATE | — | Buy |
| Mar 28, 2018 | Lake Street | INITIATE | — | Buy |
| Jul 27, 2017 | Roth Capital | INITIATE | — | Buy |
| Jan 21, 2016 | Maxim Group | INITIATE | — | Buy |
| Dec 19, 2014 | Feltl & Co. | INITIATE | — | Strong Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| May 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Apr 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Mar 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Feb 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% | |
| Jan 1, 2026 | 2 | 4 | 4 | 0 | 0 | 60% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 21, 2026
other
The Joint Corp. Announces Milind Pant Elected as Director
<p align="center"><em>- Global Executive with Extensive Digital and International Franchise-Led Growth Experience -</em></p>
May 7, 2026
earnings_calendar
JYNT Q1 2026 Earnings Scheduled — 2026-05-07
Apr 30, 2026
earnings_calendar
JYNT Q1 2026 Earnings Scheduled — 2026-04-30
Apr 27, 2026
other
The Joint Corp. Signs Asset Purchase Agreement to Sell 45 Corporate-Owned Clinics in Southern California
<p align="center"><em>- Effectively Positions The Joint as a Pure-play Franchisor -</em></p>
Apr 23, 2026
earnings
The Joint Corp. to Report 2026 First Quarter Results on Thursday, May 7 and Host Conference Call and Webcast
<p>SCOTTSDALE, Ariz., April 23, 2026 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care throug
Mar 12, 2026
earnings_calendar
JYNT Q4 2025 Earnings After Market Close — 2026-03-12
Mar 5, 2026
earnings_calendar
JYNT Q4 2025 Earnings After Market Close — 2026-03-05